'Life sciences carriers braced for wave of pharmaceutical patent infringement claims'
By Ellie Webb, Tokio Marine Kiln
Post-pandemic, life science IP litigation are likely to increase with renewed vigour, as companies attempt to ‘reclaim’ assets that may have been shared during the virus’ peak
Request a Demo Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.
Register for our free email digests: